Z. Wang and Z. Chen, Acute promyelocytic leukemia: from highly fatal to highly curable, Blood, vol.111, issue.5, pp.2505-2520, 2008.
DOI : 10.1182/blood-2007-07-102798

P. Fenaux, C. Chastang, S. Chevret, M. Sanz, H. Dombret et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapyand ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, Blood, vol.94, pp.1192-200, 1999.

M. Sanz, G. Martin, M. Gonzalez, A. Leon, C. Rayon et al., Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group, Blood, vol.103, issue.4, pp.1237-1280, 2004.
DOI : 10.1182/blood-2003-07-2462

M. Tallman, N. Ch, J. Feusner, and J. Rowe, Acute promyelocytic leukemia: evolving therapeutic strategies, Blood, vol.99, issue.3, pp.759-67, 2002.
DOI : 10.1182/blood.V99.3.759

M. Sanz, G. Martin, and F. Lo-coco, Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia, Best Practice & Research Clinical Haematology, vol.16, issue.3, pp.433-51, 2003.
DOI : 10.1016/S1521-6926(03)00040-9

S. Soignet, S. Frankel, D. Douer, M. Tallman, H. Kantarjian et al., United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia, Journal of Clinical Oncology, vol.19, issue.18, pp.3852-60, 2001.
DOI : 10.1200/JCO.2001.19.18.3852

J. Hu, Y. Liu, C. Wu, F. Xu, Z. Shen et al., Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia, Proceedings of the National Academy of Sciences, vol.106, issue.9, pp.3342-3349, 2009.
DOI : 10.1073/pnas.0813280106

C. Guglielmi, M. Martell, D. Diviero, S. Fenu, M. Vegna et al., Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases, British Journal of Haematology, vol.84, issue.4, pp.1035-1076, 1998.
DOI : 10.1038/sj.leu.2400893

A. Rovelli, A. Biondi, C. Rajoldi, A. Conter, V. Giudici et al., Microgranular variant of acute promyelocytic leukemia in children., Journal of Clinical Oncology, vol.10, issue.9, pp.1413-1421, 1992.
DOI : 10.1200/JCO.1992.10.9.1413

A. Testi, A. Biondi, L. Coco, F. Moleti, M. Giona et al., GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children, Blood, vol.106, issue.2, pp.447-53, 2005.
DOI : 10.1182/blood-2004-05-1971

S. De-botton, V. Coiteux, S. Chevret, C. Rayon, E. Vilmer et al., -Retinoic Acid and Chemotherapy, Journal of Clinical Oncology, vol.22, issue.8, pp.1404-1416, 2004.
DOI : 10.1200/JCO.2004.09.008

URL : https://hal.archives-ouvertes.fr/jpa-00214712

G. Mann, D. Reinhardt, J. Ritter, J. Hermann, K. Schmitt et al., Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children, Annals of Hematology, vol.80, issue.7, pp.417-439, 2001.
DOI : 10.1007/s002770100304

J. Ortega, L. Madero, G. Martin, A. Verdeguer, P. García et al., Retinoic Acid and Anthracycline Monochemotherapy for Children With Acute Promyelocytic Leukemia: A Multicenter Study by the PETHEMA Group, Journal of Clinical Oncology, vol.23, issue.30, pp.7632-7672, 2005.
DOI : 10.1200/JCO.2005.01.3359

R. Ribeiro and E. Rego, Management of APL in Developing Countries: Epidemiology, Challenges and Opportunities for International Collaboration, Hematology, vol.2006, issue.1, pp.162-168, 2006.
DOI : 10.1182/asheducation-2006.1.162

G. Ruiz-arguelles, Promyelocytic leukemia in Mexican mestzos, Blood, vol.89, pp.348-357, 1997.

A. Testi, S. Hadad, M. Jadiry, M. Moleti, F. Mandelli et al., Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq, Haematologica, vol.91, pp.509-521, 2006.

M. Sanz, M. Tallman, and F. Lo-coco, Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia. The oncol, pp.806-820, 2005.

M. Sanz, D. Grimwade, M. Tallman, B. Lowenberg, P. Fenaux et al., Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet, Blood, vol.113, issue.9, pp.1875-91, 2009.
DOI : 10.1182/blood-2008-04-150250

L. Coco, F. Diviero, D. Falini, B. Biondi, A. Nervi et al., Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia, Blood, vol.94, pp.12-22, 1999.

S. Frankel, A. Eardly, G. Lauwers, M. Weiss, R. Warrell et al., The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia, Annals of Internal Medicine, vol.117, issue.4, pp.292-298, 1992.
DOI : 10.7326/0003-4819-117-4-292

M. Tallman, J. Andersen, C. Schiffer, F. Appelbaum, J. Feusner et al., Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome, Blood, vol.95, pp.90-95, 2000.

S. De-botton, H. Dombret, M. Sanz, J. Miguel, D. Caillot et al., Incidence, clinical features, and outcome of all transretinoic syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia: the European APL group, Blood, vol.92, pp.2712-2720, 1998.

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-72, 1958.
DOI : 10.1214/aoms/1177731566

A. Burnett, D. Grimwade, E. Solomon, K. Wheatley, and A. Goldstone, Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all trans retinoic acid: results of the randomized MRC trial, Blood, vol.93, pp.4131-4174, 1999.

M. Tallman, J. Andersen, C. Schiffer, F. Appelbaum, J. Feusner et al., -Retinoic Acid in Acute Promyelocytic Leukemia, New England Journal of Medicine, vol.337, issue.15, pp.1021-1029, 1997.
DOI : 10.1056/NEJM199710093371501

URL : https://hal.archives-ouvertes.fr/hal-01416761

M. Sanz, G. Martin, C. Rayon, J. Esteve, M. González et al., A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR alpha-positive acute promyelocytic leukemia, Blood, vol.94, pp.3015-3036, 1999.

D. Douer, S. Preston-martin, E. Chang, P. Nichols, K. Watkins et al., High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia, Blood, vol.87, pp.308-321, 1996.

P. Hernandez, M. Milanes, E. Svarch, G. Mrtinez, and J. Ballester, High relative proportion of acute promyelocytic leukemia in children: experience of a multicenter study in Cuba, Leukemia Research, vol.24, issue.8, pp.739-779, 2000.
DOI : 10.1016/S0145-2126(00)00012-6

A. Mele, M. Stazi, A. Pulsoni, G. Visani, B. Monarca et al., Epidemiology of acute promyelocytic leukemia, Haematologica, vol.80, pp.405-413, 1995.

J. Otero, S. Santillana, and G. Fereyros, High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia, Blood, vol.88, p.377, 1996.

S. De-botton, S. Chevret, M. Sanz, H. Dombret, X. Thomas et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, British Journal of Haematology, vol.84, issue.3, pp.801-807, 2000.
DOI : 10.1056/NEJM199710093371501

J. Hernández, G. Martín, N. Gutiérrez, J. Cervera, M. Ferro et al., Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA, Haematologica, vol.86, issue.8, pp.807-820, 2001.

J. Cervera, P. Montesinos, J. Hernández-rivas, M. Calasanz, A. Aventín et al., Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy, Haematologica, vol.95, issue.3, pp.424-455, 2010.
DOI : 10.3324/haematol.2009.013243

H. Mahmoud, C. Hurwitz, W. Roberts, V. Santana, R. Ribeiro et al., Tretinoin toxicity in children with acute promyelocytic leukaemia, The Lancet, vol.342, issue.8884, pp.1394-1399, 1993.
DOI : 10.1016/0140-6736(93)92755-I

S. Castaigne, P. Lefebre, C. Csuc, E. Huguet, F. Gardin et al., Effectiveness and pharmacokinetics of low dose all-trans retinoic acid (25 mg/m 2 ) in acute promyelocytic leukemia, Blood, vol.82, pp.3560-3563, 1993.

L. Kremer, E. Van-dalen, M. Offringa, and P. Voûte, Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review, Annals of Oncology, vol.13, issue.4, pp.503-515, 2002.
DOI : 10.1093/annonc/mdf118